BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10989576)

  • 1. Correlation between Propionibacterium acnes biotypes, lipase activity and rash degree in acne patients.
    Higaki S; Kitagawa T; Kagoura M; Morohashi M; Yamagishi T
    J Dermatol; 2000 Aug; 27(8):519-22. PubMed ID: 10989576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between Propionibacterium acnes biotypes and Jumi-haidoku-to.
    Higaki S; Kitagawa T; Kagoura M; Morohashi M; Yamagishi T
    J Dermatol; 2000 Oct; 27(10):635-8. PubMed ID: 11092266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propionibacterium acnes biotypes and susceptibility to minocycline and Keigai-rengyo-to.
    Higaki S; Nakamura M; Morohashi M; Yamagishi T
    Int J Dermatol; 2004 Feb; 43(2):103-7. PubMed ID: 15125499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biotyping of Propionibacterium acnes strains isolated from patients with acne vulgaris].
    Ergin C; Kaleli I; Sahin R; Ergin S; Kaçar N
    Mikrobiyol Bul; 2006; 40(1-2):15-21. PubMed ID: 16775952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and lipolytic activity of Propionibacterium acnes (Corynebacterium acnes group I) and P. granulosum (C. acnes group II) in acne and in normal skin.
    Whiteside JA; Voss JG
    J Invest Dermatol; 1973 Feb; 60(2):94-7. PubMed ID: 4266325
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of Propionibacterium acnes lipase activity by the antifungal agent ketoconazole.
    Unno M; Cho O; Sugita T
    Microbiol Immunol; 2017 Jan; 61(1):42-44. PubMed ID: 28111792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of Cutibacterium (Propionibacterium) acnes clones from acne patients and healthy controls.
    Lomholt HB; Scholz CFP; Brüggemann H; Tettelin H; Kilian M
    Anaerobe; 2017 Oct; 47():57-63. PubMed ID: 28434779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Roxithromycin on the production of lipase and neutrophil chemotactic factor by Propionibacterium acnes.
    Akamatsu H; Tomita T; Horio T
    Dermatology; 2002; 204(4):277-80. PubMed ID: 12077521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shiunko and Chuoko, topical Kampo medicines, inhibit the expression of gehA encoding the extracellular lipase in Cutibacterium acnes.
    Nakase K; Tashiro A; Yamada T; Ikoshi H; Noguchi N
    J Dermatol; 2019 Apr; 46(4):308-313. PubMed ID: 30803018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lipase activities of Propionibacterium granulosum and Propionibacterium acnes.
    Higaki S; Nakamura M; Kitagawa T; Morohashi M; Yamagishi T
    Drugs Exp Clin Res; 2001; 27(5-6):161-4. PubMed ID: 11951573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of the Propionibacterium strains isolated from acne patients].
    Białecka A; Kasprowicz A; Kaszycki P; Marcinkiewicz J
    Med Dosw Mikrobiol; 2004; 56(1):79-92. PubMed ID: 15524399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propionibacterium acnes phylotypes and acne severity: an observational prospective study.
    Paugam C; Corvec S; Saint-Jean M; Le Moigne M; Khammari A; Boisrobert A; Nguyen JM; Gaultier A; Dréno B
    J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):e398-e399. PubMed ID: 28295699
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to the commentaries on the paper: Propionibacterium acnes strain populations in the human skin microbiome associated with acne.
    Craft N; Li H
    J Invest Dermatol; 2013 Sep; 133(9):2295-7. PubMed ID: 23774528
    [No Abstract]   [Full Text] [Related]  

  • 14. Acne and Propionibacterium acnes.
    Bojar RA; Holland KT
    Clin Dermatol; 2004; 22(5):375-9. PubMed ID: 15556721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
    Nishijima S; Kurokawa I; Katoh N; Watanabe K
    J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne.
    Gübelin W; Martínez MA; Molina MT; Zapata S; Valenzuela ME
    Rev Latinoam Microbiol; 2006; 48(1):14-6. PubMed ID: 17357569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propionibacterium acnes strain populations in the human skin microbiome associated with acne.
    Fitz-Gibbon S; Tomida S; Chiu BH; Nguyen L; Du C; Liu M; Elashoff D; Erfe MC; Loncaric A; Kim J; Modlin RL; Miller JF; Sodergren E; Craft N; Weinstock GM; Li H
    J Invest Dermatol; 2013 Sep; 133(9):2152-60. PubMed ID: 23337890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shooting at skin Propionibacterium acnes: to be or not to be on target.
    Alexeyev OA; Zouboulis CC
    J Invest Dermatol; 2013 Sep; 133(9):2292-4. PubMed ID: 23474945
    [No Abstract]   [Full Text] [Related]  

  • 19. Pan-genome and comparative genome analyses of propionibacterium acnes reveal its genomic diversity in the healthy and diseased human skin microbiome.
    Tomida S; Nguyen L; Chiu BH; Liu J; Sodergren E; Weinstock GM; Li H
    mBio; 2013 Apr; 4(3):e00003-13. PubMed ID: 23631911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propionibacterium acnes.
    Perry AL; Lambert PA
    Lett Appl Microbiol; 2006 Mar; 42(3):185-8. PubMed ID: 16478502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.